-pro-
capromab
capromab pendetide
abituzumab
alfuzosin
-col-
conatumumab
prostein
tenatumomab
tigatuzumab
figitumumab
-got-
adecatumumab
duligotuzumab
inotuzumab
naptumomab estafenatox
acrixolimab
drozitumab
nofetumomab
prostate-specific antigen
avelumab
panitumumab
patritumab
sipuleucel-T
oleclumab
PSA blood test
onartuzumab
lintuzumab
matuzumab
nacolomab tafenatox
lexatumumab
dacetuzumab
dulanermin
cixutumumab
mapatumumab
oncopeptide
ramucirumab
inotuzumab ozogamicin
dalotuzumab
prostatic adenocarcinoma
etaracizumab
pamrevlumab
samalizumab
prostate cancer
catumaxomab
-tum-
apolizumab
ertumaxomab
-mar-
altumomab
sibrotuzumab
labetuzumab
lucatumumab
immunocytokine
onapristone
bunazosin
satumomab
cabazitaxel
teprotumumab
antiprostate
malignin
p53
folliculin
tamsulosin
probasin
cemiplimab
silodosin
immunokinase
cantuzumab
arcitumomab
pemtumomab
votumumab
durvalumab
carlumab
detumomab
pritumumab
apalutamide
malignoma
minretumomab
blinatumomab
volociximab
flutamide
ensituximab
bavituximab
darolutamide
taplitumomab
prostatosphere
monospecific
-les-
naxitamab
PSA
relatlimab
besilesomab
prostasphere
prostate specific antigen
nilutamide
milatuzumab
plasmacytoma
edrecolomab